Cabrera-García et al., 2018 - Google Patents
Engineered contrast agents in a single structure for T 1–T 2 dual magnetic resonance imagingCabrera-García et al., 2018
View PDF- Document ID
- 9357332911231578777
- Author
- Cabrera-García A
- Checa-Chavarria E
- Pacheco-Torres J
- Bernabeu-Sanz
- Vidal-Moya A
- Rivero-Buceta E
- Sastre G
- Fernández E
- Botella P
- Publication year
- Publication venue
- Nanoscale
External Links
Snippet
The development of contrast agents (CAs) for Magnetic Resonance Imaging (MRI) with T1– T2 dual-mode relaxivity requires the accurate assembly of T1 and T2 magnetic centers in a single structure. In this context, we have synthesized a novel hybrid material by monitoring …
- 239000002872 contrast media 0 title abstract description 43
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cabrera-García et al. | Engineered contrast agents in a single structure for T 1–T 2 dual magnetic resonance imaging | |
| Huang et al. | Enhancing transversal relaxation for magnetite nanoparticles in MR imaging using Gd3+-chelated mesoporous silica shells | |
| CN102711840B (en) | Liposome nanoparticles for tumor magnetic resonance imaging | |
| WO2007103706A2 (en) | Nanoparticulate probe for in vivo monitoring of tissue oxygenation | |
| Dong et al. | Biocompatible and high-performance amino acids-capped MnWO 4 nanocasting as a novel non-lanthanide contrast agent for X-ray computed tomography and T 1-weighted magnetic resonance imaging | |
| Cowger et al. | Casein-coated Fe5C2 nanoparticles with superior r2 relaxivity for liver-specific magnetic resonance imaging | |
| Liu et al. | PEGylated hybrid ytterbia nanoparticles as high-performance diagnostic probes for in vivo magnetic resonance and X-ray computed tomography imaging with low systemic toxicity | |
| Lee et al. | Amphiphilic hyaluronic acid-based nanoparticles for tumor-specific optical/MR dual imaging | |
| Khatik et al. | “Magnus nano-bullets” as T1/T2 based dual-modal for in vitro and in vivo MRI visualization | |
| CN103638532B (en) | Gadolinium oxide targeted magnetic resonance contrast agent | |
| Pálmai et al. | Direct immobilization of manganese chelates on silica nanospheres for MRI applications | |
| Wang et al. | Albumin-mediated synthesis of fluoroperovskite KMnF3 nanocrystals for T1-T2 dual-modal magnetic resonance imaging of brain gliomas with improved sensitivity | |
| US7662362B2 (en) | Nanoparticulate probe for in vivo monitoring of tissue oxygenation | |
| Chen et al. | Renal clearable peptide functionalized NaGdF4 nanodots for high-efficiency tracking orthotopic colorectal tumor in mouse | |
| Marradi et al. | Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars | |
| Perera et al. | Nanoparticles of gadolinium-incorporated Prussian blue with PEG coating as an effective oral MRI contrast agent for gastrointestinal tract imaging | |
| Song et al. | Effective PEGylation of Fe3O4 nanomicelles for in vivo MR imaging | |
| Lalli et al. | Mn (ii)-Conjugated silica nanoparticles as potential MRI probes | |
| Chen et al. | Peptide-functionalized NaGdF 4 nanoparticles for tumor-targeted magnetic resonance imaging and effective therapy | |
| US20220143225A1 (en) | Ultrafine iron oxide nanoparticle-based magnetic resonance imaging t1 contrast agent | |
| EP1945192A2 (en) | Nanoscale particles used as contrasting agents in magnetic resonance imaging | |
| Ozdemir et al. | Amphiphilic peptide coated superparamagnetic iron oxide nanoparticles for in vivo MR tumor imaging | |
| Wang et al. | Geometrical confinement directed albumin-based nanoprobes as enhanced T 1 contrast agents for tumor imaging | |
| Mallik et al. | Porous Silica Nanospheres with a Confined Mono (aquated) Mn (II)-Complex: A Potential T 1–T 2 Dual Contrast Agent for Magnetic Resonance Imaging | |
| Huang et al. | Gadolinium-conjugated star-block copolymer polylysine-modified polyethylenimine as high-performance T 1 MR imaging blood pool contrast agents |